| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 4.9e-05 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -4e-05 | 1 |